Two Sigma Investments’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,684
Closed -$324K 5171
2026
Q1
$324K Buy
+9,684
New +$360K ﹤0.01% 4025
2025
Q3
Sell
-50,000
Closed -$1.62M 3723
2025
Q2
$1.62M Buy
+50,000
New +$1.43M ﹤0.01% 1967
2025
Q1
Sell
-39,800
Closed -$1.14M 3292
2024
Q4
$1.14M Buy
+39,800
New +$1.16M ﹤0.01% 2092
2024
Q2
Sell
-27,600
Closed -$763K 3123
2024
Q1
$763K Sell
27,600
-6,100
-18% -$159K ﹤0.01% 2122
2023
Q4
$821K Buy
+33,700
New +$766K ﹤0.01% 2191
2023
Q3
Sell
-31,900
Closed -$816K 3031
2023
Q2
$816K Buy
+31,900
New +$756K ﹤0.01% 2067

Other funds holding FFTY

Two Sigma Investments's FFTY Position: Q2 2026 in Review

Two Sigma Investments sold out of CapForce IBD 50 ETF (FFTY) in Q2 2026, closing a stake of 9,684 shares — an estimated $324K sold.

Two Sigma Investments first reported a position in FFTY in Q2 2023 and held it in 6 quarters. The position peaked at $1.62M in Q2 2025. 33 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.

  • Two Sigma Investments reported no remaining CapForce IBD 50 ETF position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Investments sold 9,684 CapForce IBD 50 ETF shares in Q2 2026, an estimated $324K.
  • Two Sigma Investments first reported a position in CapForce IBD 50 ETF in Q2 2023 and held it in 6 quarters.
  • Two Sigma Investments's CapForce IBD 50 ETF position peaked at $1.62M in Q2 2025.
  • 33 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.